Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies
Gene therapy relies on the delivery of genetic material to the patient’s cells in order to provide a therapeutic treatment. Two of the currently most used and efficient delivery systems are the lentiviral (LV) and adeno-associated virus (AAV) vectors. Gene therapy vectors must successfully attach, e...
Main Author: | Ana Sofia Coroadinha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/5/732 |
Similar Items
-
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
by: Claudia Piovan, et al.
Published: (2017-06-01) -
Study on Transduction of IL-24 Gene in Human Bone Marrow Mesenchymal Stem Cells by Lentiviral Vector
by: Qiugan QI, et al.
Published: (2013-01-01) -
A straightforward microfluidic-based approach toward optimizing transduction efficiency of HIV-1-derived lentiviral vectors in BCP-ALL cells
by: Seyed Esmaeil Ahmadi, et al.
Published: (2023-06-01) -
Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01) -
Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
by: Paul E. Monahan, et al.
Published: (2021-06-01)